Logo image of SN

SHARKNINJA INC (SN) Stock Fundamental Analysis

USA - NYSE:SN - KYG8068L1086 - Common Stock

91.24 USD
-2.21 (-2.36%)
Last: 10/22/2025, 8:04:01 PM
91.99 USD
+0.75 (+0.82%)
After Hours: 10/22/2025, 8:04:01 PM
Fundamental Rating

7

Overall SN gets a fundamental rating of 7 out of 10. We evaluated SN against 61 industry peers in the Household Durables industry. SN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. SN is growing strongly while it is still valued neutral. This is a good combination! These ratings could make SN a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year SN was profitable.
SN had a positive operating cash flow in the past year.
SN had positive earnings in each of the past 5 years.
In the past 5 years SN always reported a positive cash flow from operatings.
SN Yearly Net Income VS EBIT VS OCF VS FCFSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

SN has a better Return On Assets (11.42%) than 88.52% of its industry peers.
The Return On Equity of SN (23.49%) is better than 95.08% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.98%, SN belongs to the top of the industry, outperforming 85.25% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SN is in line with the industry average of 10.36%.
The 3 year average ROIC (11.61%) for SN is below the current ROIC(14.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.42%
ROE 23.49%
ROIC 14.98%
ROA(3y)7.28%
ROA(5y)N/A
ROE(3y)15.56%
ROE(5y)N/A
ROIC(3y)11.61%
ROIC(5y)N/A
SN Yearly ROA, ROE, ROICSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With a decent Profit Margin value of 8.82%, SN is doing good in the industry, outperforming 72.13% of the companies in the same industry.
SN's Profit Margin has declined in the last couple of years.
SN has a better Operating Margin (11.90%) than 75.41% of its industry peers.
In the last couple of years the Operating Margin of SN has remained more or less at the same level.
SN has a Gross Margin of 48.39%. This is amongst the best in the industry. SN outperforms 90.16% of its industry peers.
In the last couple of years the Gross Margin of SN has grown nicely.
Industry RankSector Rank
OM 11.9%
PM (TTM) 8.82%
GM 48.39%
OM growth 3Y-0.31%
OM growth 5YN/A
PM growth 3Y-3.69%
PM growth 5YN/A
GM growth 3Y7.66%
GM growth 5YN/A
SN Yearly Profit, Operating, Gross MarginsSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SN is creating some value.
The number of shares outstanding for SN has been increased compared to 1 year ago.
The debt/assets ratio for SN has been reduced compared to a year ago.
SN Yearly Shares OutstandingSN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M
SN Yearly Total Debt VS Total AssetsSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 5.91 indicates that SN is not in any danger for bankruptcy at the moment.
SN has a Altman-Z score of 5.91. This is amongst the best in the industry. SN outperforms 83.61% of its industry peers.
SN has a debt to FCF ratio of 3.07. This is a good value and a sign of high solvency as SN would need 3.07 years to pay back of all of its debts.
The Debt to FCF ratio of SN (3.07) is better than 68.85% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that SN is not too dependend on debt financing.
SN has a Debt to Equity ratio (0.32) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 3.07
Altman-Z 5.91
ROIC/WACC1.66
WACC9.05%
SN Yearly LT Debt VS Equity VS FCFSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

SN has a Current Ratio of 1.94. This is a normal value and indicates that SN is financially healthy and should not expect problems in meeting its short term obligations.
SN has a Current ratio of 1.94. This is in the lower half of the industry: SN underperforms 63.93% of its industry peers.
SN has a Quick Ratio of 1.20. This is a normal value and indicates that SN is financially healthy and should not expect problems in meeting its short term obligations.
SN's Quick ratio of 1.20 is fine compared to the rest of the industry. SN outperforms 63.93% of its industry peers.
SN does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.2
SN Yearly Current Assets VS Current LiabilitesSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.58% over the past year.
Measured over the past years, SN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.32% on average per year.
The Revenue has grown by 23.48% in the past year. This is a very strong growth!
SN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.05% yearly.
EPS 1Y (TTM)21.58%
EPS 3Y9.32%
EPS 5YN/A
EPS Q2Q%36.62%
Revenue 1Y (TTM)23.48%
Revenue growth 3Y14.05%
Revenue growth 5YN/A
Sales Q2Q%15.71%

3.2 Future

Based on estimates for the next years, SN will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.92% on average per year.
The Revenue is expected to grow by 10.37% on average over the next years. This is quite good.
EPS Next Y20.55%
EPS Next 2Y18.15%
EPS Next 3Y17.27%
EPS Next 5Y15.92%
Revenue Next Year18.33%
Revenue Next 2Y15.02%
Revenue Next 3Y13.37%
Revenue Next 5Y10.37%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SN Yearly Revenue VS EstimatesSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
SN Yearly EPS VS EstimatesSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.50, SN is valued on the expensive side.
SN's Price/Earnings is on the same level as the industry average.
SN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.57.
A Price/Forward Earnings ratio of 14.92 indicates a correct valuation of SN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SN is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.09. SN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.5
Fwd PE 14.92
SN Price Earnings VS Forward Price EarningsSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. SN is more expensive than 68.85% of the companies in the same industry.
SN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 52.3
EV/EBITDA 16.52
SN Per share dataSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of SN may justify a higher PE ratio.
SN's earnings are expected to grow with 17.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)1
PEG (5Y)N/A
EPS Next 2Y18.15%
EPS Next 3Y17.27%

0

5. Dividend

5.1 Amount

SN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SHARKNINJA INC

NYSE:SN (10/22/2025, 8:04:01 PM)

After market: 91.99 +0.75 (+0.82%)

91.24

-2.21 (-2.36%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners56.47%
Inst Owner Change-0.21%
Ins Owners2.52%
Ins Owner Change0%
Market Cap12.88B
Revenue(TTM)5.88B
Net Income(TTM)518.48M
Analysts86
Price Target138.39 (51.68%)
Short Float %8.16%
Short Ratio4.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.81%
Min EPS beat(2)15.01%
Max EPS beat(2)18.61%
EPS beat(4)4
Avg EPS beat(4)10.83%
Min EPS beat(4)3.19%
Max EPS beat(4)18.61%
EPS beat(8)8
Avg EPS beat(8)9.71%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.48%
Min Revenue beat(2)1.32%
Max Revenue beat(2)1.63%
Revenue beat(4)4
Avg Revenue beat(4)3.56%
Min Revenue beat(4)1.32%
Max Revenue beat(4)6.7%
Revenue beat(8)8
Avg Revenue beat(8)5.02%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.41%
PT rev (3m)9.36%
EPS NQ rev (1m)-0.95%
EPS NQ rev (3m)-11.33%
EPS NY rev (1m)0%
EPS NY rev (3m)1.9%
Revenue NQ rev (1m)-0.95%
Revenue NQ rev (3m)-0.66%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)1.53%
Valuation
Industry RankSector Rank
PE 20.5
Fwd PE 14.92
P/S 2.19
P/FCF 52.3
P/OCF 31.99
P/B 5.83
P/tB 14.07
EV/EBITDA 16.52
EPS(TTM)4.45
EY4.88%
EPS(NY)6.11
Fwd EY6.7%
FCF(TTM)1.74
FCFY1.91%
OCF(TTM)2.85
OCFY3.13%
SpS41.67
BVpS15.64
TBVpS6.49
PEG (NY)1
PEG (5Y)N/A
Graham Number39.57
Profitability
Industry RankSector Rank
ROA 11.42%
ROE 23.49%
ROCE 22.42%
ROIC 14.98%
ROICexc 15.94%
ROICexgc 28.5%
OM 11.9%
PM (TTM) 8.82%
GM 48.39%
FCFM 4.19%
ROA(3y)7.28%
ROA(5y)N/A
ROE(3y)15.56%
ROE(5y)N/A
ROIC(3y)11.61%
ROIC(5y)N/A
ROICexc(3y)12.86%
ROICexc(5y)N/A
ROICexgc(3y)30.15%
ROICexgc(5y)N/A
ROCE(3y)17.37%
ROCE(5y)N/A
ROICexgc growth 3Y-1.34%
ROICexgc growth 5YN/A
ROICexc growth 3Y7.9%
ROICexc growth 5YN/A
OM growth 3Y-0.31%
OM growth 5YN/A
PM growth 3Y-3.69%
PM growth 5YN/A
GM growth 3Y7.66%
GM growth 5YN/A
F-Score7
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 3.07
Debt/EBITDA 0.86
Cap/Depr 117.51%
Cap/Sales 2.66%
Interest Coverage 250
Cash Conversion 48.34%
Profit Quality 47.49%
Current Ratio 1.94
Quick Ratio 1.2
Altman-Z 5.91
F-Score7
WACC9.05%
ROIC/WACC1.66
Cap/Depr(3y)119.55%
Cap/Depr(5y)102.74%
Cap/Sales(3y)2.79%
Cap/Sales(5y)2.44%
Profit Quality(3y)68%
Profit Quality(5y)65.21%
High Growth Momentum
Growth
EPS 1Y (TTM)21.58%
EPS 3Y9.32%
EPS 5YN/A
EPS Q2Q%36.62%
EPS Next Y20.55%
EPS Next 2Y18.15%
EPS Next 3Y17.27%
EPS Next 5Y15.92%
Revenue 1Y (TTM)23.48%
Revenue growth 3Y14.05%
Revenue growth 5YN/A
Sales Q2Q%15.71%
Revenue Next Year18.33%
Revenue Next 2Y15.02%
Revenue Next 3Y13.37%
Revenue Next 5Y10.37%
EBIT growth 1Y54.11%
EBIT growth 3Y13.7%
EBIT growth 5YN/A
EBIT Next Year36.15%
EBIT Next 3Y20.57%
EBIT Next 5YN/A
FCF growth 1Y-21.98%
FCF growth 3Y20.46%
FCF growth 5YN/A
OCF growth 1Y-4.03%
OCF growth 3Y24.92%
OCF growth 5YN/A